inhibitor

Open Access
Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Reduces Aggressiveness of Cervical Carcinoma Cells
SARAH WEHBE, JULIA GALLWAS and CARSTEN GRÜNDKER

Anticancer Research May 2025, 45 (5) 1793-1805; DOI: https://doi.org/10.21873/anticanres.17559
Open Access
Effects of ERK1/2 Inhibitors on the Growth of Acute Leukemia Cells
MAI ITOH and SHUJI TOHDA

Anticancer Research December 2024, 44 (12) 5263-5270; DOI: https://doi.org/10.21873/anticanres.17354
You have access
Effects of HOXA9 Inhibitor DB818 on the Growth of Acute Myeloid Leukaemia Cells
YURI SONODA, MAI ITOH and SHUJI TOHDA

Anticancer Research April 2021, 41 (4) 1841-1847; DOI: https://doi.org/10.21873/anticanres.14950
You have access
Anti-tumor Activity of the Small Molecule Inhibitor PRI-724 Against β-Catenin-activated Hepatocellular Carcinoma
RYOSUKE GABATA, KENICHI HARADA, YUKI MIZUTANI, HIROFUMI OUCHI, KAORI YOSHIMURA, YASUNORI SATO, AZUSA KITAO, KIMINORI KIMURA, HIROYUKI KOUJI, TOMOHARU MIYASHITA, HIDEHIRO TAJIMA and TETSUO OHTA

Anticancer Research September 2020, 40 (9) 5211-5219; DOI: https://doi.org/10.21873/anticanres.14524
You have access
Exploring Flavonoids for Potential Inhibitors of a Cancer Signaling Protein PI3Kγ Kinase Using Computational Methods
MOHD REHAN, MAGED MOSTAFA MAHMOUD, SHAMS TABREZ, HANI MUTLAK A. HASSAN and GHULAM MD ASHRAF

Anticancer Research August 2020, 40 (8) 4547-4556; DOI: https://doi.org/10.21873/anticanres.14460
You have access
3PO as a Selective Inhibitor of 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3 in A375 Human Melanoma Cells
KRZYSZTOF KOTOWSKI, STANISŁAW SUPPLITT, DANIEL WICZEW, DAWID PRZYSTUPSKI, WERONIKA BARTOSIK, JOLANTA SACZKO, JOANNA ROSSOWSKA, MAŁGORZATA DRĄG-ZALESIŃSKA, OLGA MICHEL and JULITA KULBACKA

Anticancer Research May 2020, 40 (5) 2613-2625; DOI: https://doi.org/10.21873/anticanres.14232
You have access
Virtual Screening of 1,4-Naphthoquinone Derivatives for Inhibition of a Key Cancer Signaling Protein, AKT1 Kinase
MOHD REHAN and MAGED MOSTAFA

Anticancer Research July 2019, 39 (7) 3823-3833; DOI: https://doi.org/10.21873/anticanres.13532
You have access
NEK2 Is an Effective Target for Cancer Therapy With Potential to Induce Regression of Multiple Human Malignancies
TOSHIO KOKURYO, YUKIHIRO YOKOYAMA, JUNPEI YAMAGUCHI, NOBUYUKI TSUNODA, TOMOKI EBATA and MASATO NAGINO

Anticancer Research May 2019, 39 (5) 2251-2258; DOI: https://doi.org/10.21873/anticanres.13341
You have access
The Role of Histone Deacetylase Inhibitors in Uveal Melanoma: Current Evidence
MARILITA M. MOSCHOS, MARIA DETTORAKI, SOFIA ANDROUDI, DIMITRIOS KALOGEROPOULOS, ANASTASIOS LAVARIS, NIKOLAOS GARMPIS, CHRISTOS DAMASKOS, ANNA GARMPI and MICHAEL TSATSOS

Anticancer Research July 2018, 38 (7) 3817-3824; DOI: https://doi.org/10.21873/anticanres.12665
You have access
Histone Deacetylase Inhibitors as a Novel Targeted Therapy Against Non-small Cell Lung Cancer: Where Are We Now and What Should We Expect?
CHRISTOS DAMASKOS, IOANNIS TOMOS, NIKOLAOS GARMPIS, ANNA KARAKATSANI, DIMITRIOS DIMITROULIS, ANNA GARMPI, ELEFTHERIOS SPARTALIS, CHRISTOS F. KAMPOLIS, ELENI TSAGKARI, ANGELIKI A. LOUKERI, GEORGIOS-ANTONIOS MARGONIS, MICHAEL SPARTALIS, NIKOLAOS ANDREATOS, DIMITRIOS SCHIZAS, STEFANIA KOKKINELI, EFSTATHIOS A. ANTONIOU, AFRODITI NONNI, GERASIMOS TSOUROUFLIS, KONSTANTINOS MARKATOS, KONSTANTINOS KONTZOGLOU, ALKIVIADIS KOSTAKIS and PERIKLIS TOMOS

Anticancer Research January 2018, 38 (1) 37-43;

Main menu

User menu

Search

inhibitor

Pages